0000950170-24-028195.txt : 20240307
0000950170-24-028195.hdr.sgml : 20240307
20240307175328
ACCESSION NUMBER: 0000950170-24-028195
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240307
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: QVT Financial LP
CENTRAL INDEX KEY: 0001290162
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40782
FILM NUMBER: 24731591
BUSINESS ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 43RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
BUSINESS PHONE: 212-705-8800
MAIL ADDRESS:
STREET 1: 888 SEVENTH AVENUE
STREET 2: 43RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10106
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Roivant Sciences Ltd.
CENTRAL INDEX KEY: 0001635088
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 981173944
STATE OF INCORPORATION: D0
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: CLARENDON HOUSE, 2 CHURCH STREET
CITY: HAMILTON HM11
STATE: D0
ZIP: HM11
BUSINESS PHONE: 441-295-5950
MAIL ADDRESS:
STREET 1: CLARENDON HOUSE
STREET 2: 2 CHURCH STREET
CITY: HAMILTON
STATE: D0
ZIP: HM11
4
1
ownership.xml
4
X0508
4
2024-03-07
0001635088
Roivant Sciences Ltd.
ROIV
0001290162
QVT Financial LP
888 SEVENTH AVENUE, 43RD FLOOR
NEW YORK
NY
10106
false
false
true
true
Director by Deputization
false
Common Shares
2024-03-07
4
J
false
45361
0.00
D
55443
I
Held by Fourth Avenue Capital Partners LP
Common Shares
2024-03-07
4
J
false
11077765
0.00
D
14646796
I
Held by QVT Deferred Compensation Holdings Ltd.
Common Shares
2024-03-07
4
J
false
11325233
0.00
D
23105358
I
Held by QVT Financial Investment Cayman Ltd.
Common Shares
2024-03-07
4
J
false
15518673
0.00
D
19311790
I
Held by QVT Roiv Hldgs Offshore Ltd
Common Shares
2024-03-07
4
J
false
5594064
0.00
D
6837266
I
Held by QVT Roiv Hldgs Onshore Ltd.
Common Shares
2024-03-07
4
J
false
2260661
0.00
D
2763126
I
Held by QVT P&E Roiv Hldgs Ltd.
On March 7, 2024, each of QVT Roiv Hldgs Onshore Ltd. and QVT Roiv Hldgs Offshore Ltd. (together, "QVT Roiv"), Fourth Avenue Capital Partners LP ("Fourth Avenue"), QVT P&E Roiv Hldgs Ltd. ("QVT P&E"), QVT Deferred Compensation Holdings Ltd ("QVT DCH") and QVT Financial Investment Cayman Ltd. ("QVT FIC") made an in-kind distribution on a pro rata basis, for no consideration.
Aggregately, following the transactions described above, QVT Financial LP ("QVT"), a Delaware limited partnership, may be deemed to be the beneficial owner of 66,719,779 common shares (the "Shares") of Roivant Sciences Ltd., consisting of the Shares owned by QVT Roiv, Fourth Avenue, QVT P&E, QVT DCH and QVT FIC. QVT Financial GP LLC ("QVT Financial GP"), a Delaware limited liability company, is the general partner of QVT and may be deemed to beneficially own the same number of Shares reported by QVT.
QVT provides certain investment advisory services for, and thereby may be deemed to beneficially own the Shares held by, Fourth Avenue, QVT P&E, QVT DCH and QVT FIC. QVT disclaims beneficial ownership of such Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.
QVT is the investment manager of QVT Roiv, shares voting and investment control over the Shares held directly by QVT Roiv and therefore may be deemed to beneficially own such Shares. QVT disclaims beneficial ownership of such Shares, except to the extent of any pecuniary interest therein, and the inclusion of these Common Shares in this report shall not be deemed an admission of beneficial ownership of all of the reported Common Shares for purposes of Section 16 or for any other purpose.
/s/ Meg Eisner
2024-03-07